Inhibition of the canonical Wnt pathway by high glucose can be reversed by parathyroid hormone-related protein in osteoblastic cells.
about
Autophagy impairment aggravates the inhibitory effects of high glucose on osteoblast viability and functionMiR-378 overexpression attenuates high glucose-suppressed osteogenic differentiation through targeting CASP3 and activating PI3K/Akt signaling pathway.Treatment with N- and C-terminal peptides of parathyroid hormone-related protein partly compensate the skeletal abnormalities in IGF-I deficient mice.Sclerostin antibody treatment improves fracture outcomes in a Type I diabetic mouse model.Acceleration of bone regeneration by activating Wnt/β-catenin signalling pathway via lithium released from lithium chloride/calcium phosphate cement in osteoporosis.Parathyroid Hormone-Related Protein Analogs as Osteoporosis Therapies.Lgr4 Expression in Osteoblastic Cells Is Suppressed by Hydrogen Peroxide Treatment.Functional roles of the nuclear localization signal of parathyroid hormone-related protein (PTHrP) in osteoblastic cells.High glucose alters the secretome of mechanically stimulated osteocyte-like cells affecting osteoclast precursor recruitment and differentiation.Adverse Effects of Diabetes Mellitus on the Skeleton of Aging Mice.The Osteogenic Priming of Mesenchymal Stem Cells is Impaired in Experimental Diabetes.PTHrP-Derived Peptides Restore Bone Mass and Strength in Diabetic Mice: Additive Effect of Mechanical Loading.Parathyroid hormone-related protein exhibits antioxidant features in osteoblastic cells through its N-terminal and osteostatin domains.Runx2 alleviates high glucose-suppressed osteogenic differentiation via PI3K/AKT/GSK3β/β-catenin pathway.Aluminum Trichloride Inhibited Osteoblastic Proliferation and Downregulated the Wnt/β-Catenin Pathway.
P2860
Q28585332-72770110-F19C-4A5B-921F-5752BE029FA9Q34502004-67B919C1-70F2-4D5E-9BF3-DA7895134BEDQ35087758-201740E6-D95E-49A7-8299-C0932AC5134AQ36253807-156E7371-E6E7-4173-A9F4-61862C692B92Q37719513-E8BFF897-C478-42C5-8517-401817188547Q38563889-A22735E8-AC54-477D-B3AE-0F1B5CCA9E50Q38730426-25ABCA32-BEA4-4C47-B945-954369D95012Q42005257-3C8B71F1-A5CD-4E86-8BA9-D5D539C94385Q42504968-BE437962-582C-40A6-B641-E2B14007D3AEQ46174399-D6EA71E3-FD42-40AA-B65C-710FABD654E6Q47741794-6FD0B33E-352E-4314-AA04-C6B8F4A61317Q48038374-B12DBC48-AD57-40D0-B4DE-B9A59DA6F258Q50058849-65C41F1E-C64A-4FE7-B124-6E9D5AAA05F4Q50208718-3EF95803-1B8C-4C3D-987A-9232FC748665Q51335065-25EFF1AD-C59E-4170-9D5D-9B9D31E1FBD9
P2860
Inhibition of the canonical Wnt pathway by high glucose can be reversed by parathyroid hormone-related protein in osteoblastic cells.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Inhibition of the canonical Wn ...... protein in osteoblastic cells.
@en
Inhibition of the canonical Wn ...... protein in osteoblastic cells.
@nl
type
label
Inhibition of the canonical Wn ...... protein in osteoblastic cells.
@en
Inhibition of the canonical Wn ...... protein in osteoblastic cells.
@nl
prefLabel
Inhibition of the canonical Wn ...... protein in osteoblastic cells.
@en
Inhibition of the canonical Wn ...... protein in osteoblastic cells.
@nl
P2093
P2860
P50
P356
P1476
Inhibition of the canonical Wn ...... protein in osteoblastic cells.
@en
P2093
Adela García-Martín
Ana López-Herradón
Francisco C Pérez-Martínez
Pedro Esbrit
P2860
P304
P356
10.1002/JCB.24535
P577
2013-08-01T00:00:00Z